Related Experiment Video
Updated: Aug 1, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
[Dr. Sergey P. Botkin's case sheet].
1Sechenov First Moscow State Medical University (Sechenov University).
This case study analyzes Botkin's cardiac disease, highlighting its progression and diagnostic challenges. It examines the interplay of ischemic heart disease and gallstone disease in a prominent Russian physician.
Area of Science:
- Cardiology
- Internal Medicine
- Medical History
Context:
- Analysis of a historical medical case (Botkin's) provides insights into cardiac disease progression.
- The case involves a prominent figure in Russian medical history, Dr. Sergey P. Botkin.
- Focuses on the comorbidity of ischemic heart disease and gallstone disease.
Purpose:
- To characterize the features of Botkin's disease course at all stages of its cardiological continuum.
- To assess modern diagnostic capabilities and management approaches for similar cardiac conditions.
- To discuss the specific comorbidity of ischemic heart disease and gallstone disease in this historical context.
Summary:
- Presents and discusses Botkin's case sheet detailing his cardiac disease.
- Applies modern clinical cardiology to analyze symptoms, disease course, and diagnostic/management strategies.
- Explores the co-occurrence of ischemic heart disease and gallstone disease in Dr. Botkin's case.
Impact:
- Offers a historical perspective on cardiac disease management and diagnosis.
- Provides a clinical case study for understanding complex cardiac comorbidities.
- Contributes to the understanding of cardiovascular disease evolution and treatment strategies.
More Related Videos
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025